skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
02/24/2004
Application #:
10317464
Filing Dt:
12/12/2002
Publication #:
Pub Dt:
07/10/2003
Inventors:
Michael R. Myers, Wei He, Alfred P. Spada, Martin P. Maguire
Title:
QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56LCK TYROSINE KINASES
Assignment: 1
Reel/Frame:
014159/0686Recorded: 11/26/2003Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/09/1999
Exec Dt:
01/13/1999
Exec Dt:
01/08/1999
Exec Dt:
01/07/1999
Assignee:
500 ARCOLA ROAD
COLLEGEVILLE, PENNSYLVANIA 19426-0107
Correspondent:
AVENTIS PHARMACEUTICALS INC.
RAYMOND S. PARKER, III
ROUTE 202-206/P.O. BOX 6800
BRIDGEWATER, NJ 08807-0800
Assignment: 2
Reel/Frame:
014187/0207Recorded: 12/10/2003Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/15/1999
Assignee:
300 SOMERSET CORPORATE BOULEVARD
BRIDGE WATER, NEW JERSEY 08807-2854
Correspondent:
AVENTIS PHARMACEUTICALS INC.
RAYMOND S. PARKER, III, PH.D.
P.O. BOX 6800
BRIDGEWATER, NJ 08807-0900
Assignment: 3
Reel/Frame:
014188/0823Recorded: 12/11/2003Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/31/2001
Assignee:
300 SOMERSET CORPORATED BOULEVARD
BRIDGEWATER, NEW JERSEY 08807-2854
Correspondent:
AVENTIS PHARMACEUTICALS INC.
RAYMOND S. PARKER III, PH.D.
P.O. BOX 6800, ROUTE 202-206
BRIDGEWATER, NJ 08807-0800

Search Results as of: 05/10/2024 01:31 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT